Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Catchpoole

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Oncotarget|May 14, 2017
Correction: LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastomaGabriella Cunha Vieira, S Chockalingam, Zsombor Melegh, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2016
Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and ParagangliomaAidan Flynn, Trisha Dwight, Jessica Harris, et al.
Molecular Oncology|December 6, 2014
Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cellsJi Hyun Park, Marianna Szemes, Gabriella Cunha Vieira, et al.
Cancer Research|October 7, 2004
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastomaJun S Wei, Braden T Greer, Frank Westermann, et al.
Genes, Chromosomes & Cancer|October 23, 2021
Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancerDianne E Sylvester, Yuyan Chen, Natalie Grima, et al.
Haematologica|October 30, 2025
Clinical and germline risk factors for multiple treatment-related toxicities in pediatric acute lymphoblastic leukemiaMarion K Mateos, Chelsea Mayoh, Patricia Sullivan, et al.
Plos One|October 14, 2014
Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposuresTiffany-Jane Evans, Elizabeth Milne, Denise Anderson, et al.
Cancer Research|January 11, 2007
Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysisCraig C Whiteford, Sven Bilke, Braden T Greer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2018
Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk <i>MYCN</i>-Not-Amplified Human NeuroblastomaJun S Wei, Igor B Kuznetsov, Shile Zhang, et al.
Haematologica|February 11, 2021
Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemiaMarion K Mateos, Glenn M Marshall, Pasquale M Barbaro, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Oncotarget|May 14, 2017
Correction: LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastomaGabriella Cunha Vieira, S Chockalingam, Zsombor Melegh, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2016
Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and ParagangliomaAidan Flynn, Trisha Dwight, Jessica Harris, et al.
Molecular Oncology|December 6, 2014
Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cellsJi Hyun Park, Marianna Szemes, Gabriella Cunha Vieira, et al.
Cancer Research|October 7, 2004
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastomaJun S Wei, Braden T Greer, Frank Westermann, et al.
Genes, Chromosomes & Cancer|October 23, 2021
Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancerDianne E Sylvester, Yuyan Chen, Natalie Grima, et al.
Haematologica|October 30, 2025
Clinical and germline risk factors for multiple treatment-related toxicities in pediatric acute lymphoblastic leukemiaMarion K Mateos, Chelsea Mayoh, Patricia Sullivan, et al.
Plos One|October 14, 2014
Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposuresTiffany-Jane Evans, Elizabeth Milne, Denise Anderson, et al.
Cancer Research|January 11, 2007
Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysisCraig C Whiteford, Sven Bilke, Braden T Greer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2018
Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk <i>MYCN</i>-Not-Amplified Human NeuroblastomaJun S Wei, Igor B Kuznetsov, Shile Zhang, et al.
Haematologica|February 11, 2021
Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemiaMarion K Mateos, Glenn M Marshall, Pasquale M Barbaro, et al.
Pageof 8